Status:
COMPLETED
CBD, Immune Function, and Neural Health
Lead Sponsor:
University of Northern Colorado
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Chronic inflammation, which is defined as a persistent, low-grade inflammatory response within the body, is associated with many of the negative health conditions which are prevalent in our society to...
Detailed Description
In this double-blind investigation, participants will undergo 8 total visits separated by an 8-week intervention period. One week prior to the intervention period, participants will complete a blood d...
Eligibility Criteria
Inclusion
- Participants must be within 18 and 50 years of age
- Abstained from cannabis (either THC and/or CBD) for the past 6 weeks
- Have a BMI of 29.9 or below
- Completes at least 150 minutes of moderate to vigorous physical activity per week.
- Able and willing to commit to an 8-week intervention schedule
Exclusion
- Significant cardiovascular disorders including but not limited to serious arrhythmias, cardiomyopathy, congestive heart failure, stroke, or transient ischemic attacks, peripheral vascular disease with intermittent claudication, acute, chronic or recurrent thrombophlebitis.
- Diagnosed neurological disorders including but not limited to brain tumors, brain injuries, Alzheimer's Disease, Parkinson's Disease, multiple sclerosis, epilepsy, and seizures.
- Regular use of drugs that significantly alter brain activity such as selective serotonin reuptake inhibitors, benzodiazepines, and others used to treat anxiety, panic, stress, sleep disorders, or increases the risk of sedation and drowsiness.
- Head trauma with loss of consciousness for more than 30 mins.
Key Trial Info
Start Date :
May 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 18 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04881539
Start Date
May 15 2021
End Date
March 18 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Northern Colorado
Greeley, Colorado, United States, 80639